We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Graphene Sandwich Technology Reveals Clues into Inner Workings of Proteins

By LabMedica International staff writers
Posted on 30 Dec 2013
British scientists have discovered that the most fragile, microscopic compounds can be saved from the harmful effects of radiation when under the microscope if they are “sandwiched” between two sheets of graphene. More...
The technique could soon be the answer to being able to directly study every single individual atom in a protein chain—something that has not yet been achieved—and transform the determination of cell structure, how the immune system reacts to viruses, and help in the design of new antiviral drugs.

Seeing the structure of some the smallest of objects at the atomic level, such as proteins and other sensitive two-dimensional (2D) substances, requires a powerful electron microscope. This is extremely problematic because the radiation from the electron beam can kill the very fragile object being imaged before any valuable data can be effectively recorded. However, by protecting fragile objects between two sheets of graphene they can be imaged for longer without damage under the electron beam, making it possible to quantitatively identify every single atom within the structure.

This technique has been shown to be very successful on the test case of a fragile inorganic 2D crystal, and the study’s findings were published November 26, 2013, in the journal ACSNano. The research was conducted by investigators from the University of Manchester (UK) and the SuperSTEM facility, which is located at Science & Technology Facilities’ Council (STFC) Daresbury Laboratory (UK), and funded by the Engineering and Physical Sciences Research Council (EPSRC; Swindon, Wiltshire, UK).

The team of scientists, which included Sir Kostya Novoselov, who shared a Nobel Prize in Physics in 2010 for utilizing the remarkable characteristics of graphene, was able to visualize the effects of encasing a microscopic crystal of another highly delicate 2D material, molybdenum disulfide, between two sheets of graphene. They discovered that they were able to apply a high electron beam to directly image, identify, and obtain complete chemical analysis of each and every atom within the molybdenum di-sulfide sheet, without causing any defects to the compound through radiation.

The University of Manchester’s Dr. Recep Zan, who led the research team, said, “Graphene is a million times thinner than paper, yet stronger than steel, with fantastic potential in areas from electronics to energy. But this research shows its potential in biochemistry could also be just as significant, and could eventually open up all sorts of applications in the biotechnology arena.”

Prof. Quentin Ramasse, scientific director at SuperSTEM ,added, “What this research demonstrates is not so much about graphene itself, but how it can impact the detail and accuracy at which we can directly study other inorganic 2D materials or highly fragile molecules. Until now, this has mostly been possible through less direct and often complicated methods such as protein crystallography, which do not provide a direct visualization of the object in question. This new capability is particularly exciting, because it could pave the way to being able to image every single atom in a protein chain for example, something which could significantly impact our development of treatments for conditions such as cancer, Alzheimer’s and HIV.”

Related Links:

University of Manchester
Science & Technology Facilities’ Council Daresbury Laboratory



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.